← 홈

CGT · 혈액암 (AML/ALL)

382개 · ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-8 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 382개
CGTAHOTFDACuratedFDABiologicNovartisApproved

tisagenlecleucel (Kymriah, tisa-cel)

ALL, DLBCL, FL · CD19

#CD19#CGT#Approved#FDA승인#바이오정보모아추천+5
효능 ORR 82.3%임상시험 48상태 APPROVED
CGTAAVBHOTFDACuratedFDABiologicSpark TherapeuticsHuman RPE65 cDNAApproved

voretigene neparvovec (Luxturna, AAV2-hRPE65v2, voretigene neparvovec-rzyl)

Inherited retinal dystrophy due to confirmed biallelic RPE65 mutations · RPE65 (AAV2)

#RPE65AAV2#CGT#Approved#FDA승인#바이오정보모아추천+5
임상시험 7상태 APPROVED
CGTABiologicstaleAstraZenecaPhase 2

autologous CD19-directed chimeric antigen receptor (CAR, autologous CD19-directed chimeric antigen receptor, autologous CD19-directed chimeric antigen receptor (CAR) T-cells)

Relapsed Non Hodgkin Lymphoma; Relapsed Adult ALL · CD19

#CD19#CGT#Phase2#인기#세포유전치료+5
효능 ORR 77.3%임상시험 96상태 RECRUITING
CGTBBiologicstaleBioceltech Therapeutics, Ltd.Phase 1

CD19 CAR T cells (CD19 CAR T cells)

B-cell Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#인기#세포유전치료+5
효능 ORR 88%임상시험 73상태 RECRUITING
CGTBiologicstaleAmgenPhase 3

Asparaginase Erwinia chrysanthemi (Asparaginase Erwinia chrysanthemi, Asparaginase Erwinia chrysanthemi (recombinant)-rywn, recombinant)

Acute Lymphoblastic Leukemia; Acute Lymphoblastic Lymphoma · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#CGT#Phase3#인기#세포유전치료+5
효능 ORR 18%임상시험 64상태 RECRUITING
CGTBiologicstaleFundamenta Therapeutics, Ltd.Phase 1

Chimeric Antigen Receptor T-cells (Chimeric Antigen Receptor T-cells)

Leukemia, Acute Lymphocytic (ALL); Leukemia, Acute Myelogenous (AML) · Platinum-Resistant Ovarian Carcinoma

#Platinum-ResistantOvarianCarcino#CGT#Phase1#인기#세포유전치료+5
효능 ORR 67%임상시험 63상태 ACTIVE
CGTBiologicstaleHoffmann-La RochePhase 1

Interferon-Alfa-2b (Interferon-Alfa-2b)

Solid Cancers · Adult T-cell Leukemia-Lymphoma

#AdultT-cellLeukemia-Lymphoma#CGT#Phase1#인기#세포유전치료+5
효능 ORR 24%임상시험 63상태 ACTIVE
CGTBiologicstaleNeotropixPhase 1

biological agent (Seneca Valley Virus, Seneca Valley Virus (biological agent))

Carcinoid; Neuroendocrine · Carcinoid

#Carcinoid#CGT#Phase1#인기#세포유전치료+5
임상시험 63상태 ACTIVE
CGTBiologicstalePorteus, Matthew, MDPhase 1

Allogeneic Stem Cell Transplant (Allogeneic Stem Cell Transplant)

Hematologic Diseases · Hematologic Diseases

#HematologicDiseases#CGT#Phase1#인기#세포유전치료+4
효능 ORR 72.7%임상시험 62상태 RECRUITING
CGTBiologicstaleShenzhen BinDeBio Ltd.mayPhase 2

CAR-T cell immunotherapy (CAR-T cell immunotherapy)

B-cell Acute Lymphoblastic Leukemia; Lymphoma · GD2

#GD2#CGT#Phase2#인기#세포유전치료+5
효능 ORR 80.3%임상시험 62상태 ACTIVE
CGTBiologicstaleMerck Sharp & Dohme LLCPhase 2

Stem cell infusion (Stem cell infusion)

Leukemia; Lymphoma · Leukemia

#Leukemia#CGT#Phase2#인기#세포유전치료+5
효능 ORR 90%임상시험 62상태 ACTIVE
CGTBiologicstaleYake Biotechnology Ltd.Phase 1

chimeric antigen receptor T cell treatment (chimeric antigen receptor T cell treatment)

T Cell Lymphoma; T-cell Leukemia · FRα

#FR#CGT#Phase1#인기#세포유전치료+5
효능 ORR 80.3%임상시험 62상태 ACTIVE
CGTBiologicstaleGenzyme, a Sanofi CompanyPhase 2

stem cells (stem cells)

Acute Lymphoblastic Leukemia; Acute Myelocytic Leukemia · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#CGT#Phase2#인기#세포유전치료+5
임상시험 62상태 DISCONTINUED
CGTBiologicstaleAlliance for Clinical Trials in…Phase 3

Allopurinol (Allopurinol)

B Acute Lymphoblastic Leukemia · Fallopian Tube Cancer

#FallopianTubeCancer#CGT#Phase3#인기#세포유전치료+5
임상시험 61상태 DISCONTINUED
CGTBiologicstaleHebei Senlang Biotechnology Inc…Phase 2

Autologous CAR-T cells (Autologous CAR-T cells)

Leukemia; Lymphoma · FRα

#FR#CGT#Phase2#인기#세포유전치료+5
효능 ORR 80.3%임상시험 61상태 ACTIVE
CGTBiologicstaleGlaxoSmithKlineSN-38 also augmented IL-10 …Phase 2

topotecan hydrochloride (topotecan hydrochloride)

Fallopian Tube Carcinosarcoma; Fallopian Tube Clear Cell Adenocarcinoma · Fallopian Tube Cancer

#FallopianTubeCancer#CGT#Phase2#인기#세포유전치료+5
효능 ORR 95.4%임상시험 61상태 DISCONTINUED
CGTBiologicAbbottPhase 2

Pegylated asparaginase (Pegylated asparaginase)

B Lymphoblastic Leukemia · B Lymphoblastic Leukemia

#BLymphoblasticLeukemia#CGT#Phase2#인기#세포유전치료+4
효능 ORR 14.3%임상시험 60상태 RECRUITING
CGTBiologicstaleAbbottvedotinPhase 2

Zidovudine (Zidovudine)

Lymphoproliferative Disorder; HHV-8 · Adult T-cell Leukemia-Lymphoma

#AdultT-cellLeukemia-Lymphoma#CGT#Phase2#인기#세포유전치료+5
임상시험 60상태 RECRUITING
CGTBiologicstaleSMT bio Co., Ltd.Phase 2

allogeneic Natural Killer cell ('SMT-NK' Inj, 'SMT-NK' Inj (allogeneic Natural Killer cell))

Biliary Tract Cancer · Biliary Tract Cancer

#BiliaryTractCancer#CGT#Phase2#인기#세포유전치료+4
효능 ORR 42%임상시험 58상태 ACTIVE
CGTBiologicstalePaolo Caimi, MDPhase 1

Allogeneic NK cells (Allogeneic NK cells)

Non Hodgkin Lymphoma; B-cell Non Hodgkin Lymphoma · Non Hodgkin Lymphoma

#NonHodgkinLymphoma#CGT#Phase1#인기#세포유전치료+4
효능 ORR 5%임상시험 58상태 RECRUITING

1 / 20 페이지

← 이전다음 →